To investigate whether this mechanism may also be relevant in humans, we measured TGF-β1 and UCP3 expression in non-failing hearts and in myocardium from patients with DCM who had either been treated or not been treated with metoprolol. The gene discussed is TGFB1; the disease is familial dilated cardiomyopathy.